BlackMesh delivers HIPAA-compliant cloud platform

Katherine Davis | | Health Exec | Precision Medicine

Ashburn, Virginia-based BlackMesh has launched a HIPAA-compliant cloud platform designed to meet the everyday technical and regulatory needs of clinics and hospitals.

The program offers high security for medical data, including EMR, EHR and other healthcare applications, according to a statement from the company.

BlackMesh, founded in 2003, has datacenter locations in Reston, Virginia, Las Vegas and Toronto. Its new platform will better help healthcare organizations use telehealth services while incorporating reliable resource sharing.

“We’re thrilled to officially launch a cloud solution that serves the healthcare community’s unique and complex needs—such as cost savings and secure high-volume data storage,” said BlackMesh President Eric Mandel in a statement. “By offering a compliant and secure cloud platform for managing and maintaining data, BlackMesh is helping the health services industry better collaborate and serve the public.”

 

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup